COMMUNIQUÉS West-GlobeNewswire

GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel

28/06/2018 - 22:57

First of Three ePlex Molecular Multiplex Panels for the Diagnosis and Management of Bloodstream Infections That Can Lead to Sepsis CARLSBAD, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: [...]

Topline results of PELICAN trial and update on triple combo development plans

28/06/2018 - 22:36

First trial to evaluate C2 corrector GLPG2737 in CF patients treated with Orkambi GLPG2737 achieved primary efficacy endpoint and was well-tolerated in patients Significant further reduction in sweat chloride [...]

Novartis presents new data demonstrating long-term efficacy, safety and tolerability of Aimovig® (erenumab) in patients with chronic and episodic migraine

28/06/2018 - 22:31

Results from a one-year study of efficacy and safety of Aimovig in chronic migraine and data from a three-year analysis assessing safety and tolerability of Aimovig in episodic migraine will be presented at AHS Aimovig [...]

Mount Tam Biotechnologies Announces Appointment of New Member to the Board of Directors

28/06/2018 - 22:30

NOVATO, CA, June 28, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam" or the “Company”) (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to [...]

Voyager Therapeutics Appoints Andre Turenne as President and Chief Executive Officer

28/06/2018 - 22:30

CAMBRIDGE, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]

Aclaris Therapeutics Announces Positive Interim Data from Phase 2 study of ATI-502 (a topical JAK inhibitor) in Patients with Alopecia Areata

28/06/2018 - 22:30

WAYNE, Pa., June 28, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]

Innovation Pharmaceuticals Announces $7 million Milestone Funding Agreement with Aspire Capital

28/06/2018 - 22:30

$2 million Received on Signing the Agreement BEVERLY, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announced that it [...]

Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers

28/06/2018 - 22:30

MENLO PARK, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Entellus Medical Inc., now part of Stryker, today announced the publication of a multi-site market research study evaluating symptom severity for nasal airway [...]

Biogen Exercises Option to Increase Ownership in Samsung Bioepis

28/06/2018 - 22:06

Biogen will pay Samsung BioLogics approximately $700 million to increase its ownership in Samsung Bioepis to approximately 49.9% Transaction expected to close in the second half of 2018 CAMBRIDGE, Mass., June 28, 2018 ( [...]

TESARO Enters Asset Purchase Agreement with TerSera® Therapeutics LLC for VARUBI® in the U.S. and Canada

28/06/2018 - 22:05

TESARO to Receive $40 Million, plus Potential for Additional Milestone Payments and Royalties TESARO Retains ex-North America Rights and Continues to Market VARUBY ® in Europe WALTHAM, Mass., June 28, 2018 (GLOBE [...]

electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation (nVNS) in Headache Disorders at the 60th Annual Meeting of the American Headache Society

28/06/2018 - 22:01

BASKING RIDGE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, announced today it will present six abstracts across three primary headache [...]

Ziopharm Oncology Enrolls First Patient in Phase 1 Trial Evaluating Combination Therapy of Controlled IL-12 and OPDIVO®

28/06/2018 - 22:01

Phase 1 trial to evaluate Ad-RTS-hIL-12 plus veledimex in combination with nivolumab for treatment of recurrent glioblastoma BOSTON, June 28, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP), a [...]

MAC Clinical Research Announces Presentation at the 60th Annual Scientific Meeting of the American Headache Society

28/06/2018 - 22:01

– New clinical trial data highlight potential of an evoked migraine model to test potential efficacy for investigational products intended to treat acute migraine – – Collaboration between MAC Clinical Research and [...]

Gemcabene Meets Primary Endpoint in INDIGO-1 Study of Severe Hypertriglyceridemia (SHTG) Patients

28/06/2018 - 22:01

Gemcabene demonstrated statistically significant lowering of triglycerides (TGs) in SHTG Secondary endpoints achieved included statistically significant reductions in serum LDL-C, non-HDL-C, VLDL-C, apoB, apoE, apoCIII [...]

Trevena announces successful completion of Phase 1 study of TRV250 for acute migraine

28/06/2018 - 22:01

– Pharmacokinetics, safety, and tolerability support advancement of TRV250 to Phase 2 – – Data suggest potential for TRV250 to be the first selective delta receptor modulator – CHESTERBROOK, Pa., June 28, 2018 (GLOBE [...]

ALRT announces launch of the Integrated ALRT Diabetes Solution (“Integrated Solution”)

28/06/2018 - 21:58

The Integrated Solution will include ALRT Diabetes Solution software, blood glucose test supplies and diabetes management administered by Centers of Excellence for Diabetes Care RICHMOND, Va., June 28, 2018 (GLOBE [...]

CAPS® Expert Appointed to the Board of Pharmacy Specialties’ Council

28/06/2018 - 20:50

IRVINE, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS ® ) is proud to announce that Sharon Durfee, RPh, BCNSP, has been selected as a member of the Board of Pharmacy [...]

League and Molecular You Partner to Provide Employees with Personalized Health Assessments for Early Detection and Preventive Healthcare

28/06/2018 - 18:30

Opens up personal health assessments to the whole workforce VANCOUVER, British Columbia, June 28, 2018 (GLOBE NEWSWIRE) -- League Inc., the disruptive health benefits platform, and Molecular You, the personalized health [...]

NeuroMetrix PR Campaign Wins Gold at the Publicity Club of New England 2018 Bell Ringer Awards

28/06/2018 - 18:27

“Moving Beyond Opioids: How Technological Innovations Can Impact Chronic Pain” earns top award in healthcare publicity campaign category WALTHAM, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) [...]